Session Information

  • WCLC 2020

    2020 World Conference on Lung Cancer

    Conference Program for the 2020 World Conference on Lung Cancer in Singapore


    Presentation Date(s):  
    • January 28 - 31, 2021
    • Total Presentations: 1597

    All times listed are in Singapore time (GMT+8)

    PL - Plenary
    PS - Presidential Symposium
    ES - Education Session
    OA - Oral Session
    MA - Mini Oral Session
    FP - Featured Posters
    P - Posters
    IS - Industry Symposium
    JICC - Joint IASLC-CAALC-CSCO Session

Filter Results:

Show Only CME Accredited Sessions

  • +

    PL01 - Opening Plenary Session (Japanese, Mandarin, Spanish Translation Available)

    • 18:00 - 20:00
    • 1/28/2021
    • Location: Scientific Program Auditorium
    • IASLC CME Accredited
    • Type: Plenary
    • Track: N.A.
    • +

      PL01.02 - Chair

      18:05 - 18:10  |  Presenter: Daniel SW Tan

      • Abstract

      No abstract available for this presentation

  • +

    FP14 - Targeted Therapy - Clinically Focused

    • 00:00 - 00:00
    • 1/28/2021
    • Location: ePoster Hall
    • Type: Posters (Featured)
    • Track: Targeted Therapy - Clinically Focused
    • +

      FP14.10 - Efficacy and Safety of Selpercatinib (LOXO-292) in East Asian Patients with RET Fusion-Positive NSCLC

      00:00 - 00:00  |  Presenter: Herbert H Loong

      • Abstract

      Loading...

    • +

      FP14.13 - Molecular Characterisation and Clinical Outcomes in RET Rearranged Non-Small Cell Lung Cancer (NSCLC)

      00:00 - 00:00  |  Presenter: Aaron C Tan

      • Abstract

      Loading...

  • +

    P37 - Pathology - Biomarker Testing

    • 00:00 - 00:00
    • 1/28/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters
    • Track: Pathology, Molecular Pathology and Diagnostic Biomarkers
    • +

      P37.18 - Lung NSCLC Molecular Diagnostic Comparison Between NGS and Multiplex PCR Assays

      00:00 - 00:00  |  Presenter: Kiat Hon Tony Lim

      • Abstract

      Loading...

  • +

    P38 - Pathology - Pathology/Staging

    • 00:00 - 00:00
    • 1/28/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters
    • Track: Pathology, Molecular Pathology and Diagnostic Biomarkers
    • +

      P38.03 - Immunohistochemical, Histologic and Genomic Characterisation of Early Stage Pulmonary Invasive Mucinous Adenocarcinoma

      00:00 - 00:00  |  Presenter: Aaron C Tan

      • Abstract

      Loading...

  • +

    P59 - Tumor Biology and Systems Biology - Basic and Translational Science - Genomics

    • 00:00 - 00:00
    • 1/28/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters
    • Track: Tumor Biology and Systems Biology - Basic and Translational Science
    • +

      P59.08 - THOR: Multi-Ethnic, Open Access Thoracic Cancer Genomics Resource

      00:00 - 00:00  |  Presenter: Anders Skanderup

      • Abstract

      Loading...

  • +

    P69 - Tumor Biology and Systems Biology - Basic and Translational Science - RTK/EGFR

    • 00:00 - 00:00
    • 1/28/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters
    • Track: Tumor Biology and Systems Biology - Basic and Translational Science
    • +

      P69.05 - Molecular and Cellular Heterogeneity Underpin Treatment Response Across a Spectrum of EGFR-Mutant Non-Small Cell Lung Cancer

      00:00 - 00:00  |  Presenter: Ju Yuan

      • Abstract

      Loading...

  • +

    P76 - Targeted Therapy - Clinically Focused - EGFR

    • 00:00 - 00:00
    • 1/28/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters
    • Track: Targeted Therapy - Clinically Focused
    • +

      P76.03 - Efficacy and Safety of Capmatinib Plus Nivolumab in Pretreated Patients with EGFR Wild-Type Non–Small Cell Lung Cancer

      00:00 - 00:00  |  Presenter: Enriqueta Felip

      • Abstract

      Loading...

    • +

      P76.46 - First-Line Osimertinib in Asian Patients with Advanced EGFR-Mutant Lung Cancer  

      00:00 - 00:00  |  Presenter: Wan-Ling Tan

      • Abstract

      Loading...

    • +

      P76.88 - Real-World Data of Osimertinib in Patients with Metastatic EGFRm+ NSCLC who Progressed on First-Line EGFR TKIs

      00:00 - 00:00  |  Presenter: Jun Ma

      • Abstract

      Loading...

  • +

    OA01 - Established Drugs in Special Populations and New Drugs in Established Populations

    • 09:15 - 10:15
    • 1/29/2021
    • Location: Scientific Program Auditorium
    • IASLC CME Accredited
    • Type: Oral
    • Track: Immunotherapy (Phase II/III Trials)
    • +

      OA01.06 - Randomised Phase 2 Study of Nivolumab (N) Versus Nivolumab and Ipilimumab (NI) Combination in EGFR Mutant NSCLC

      09:40 - 09:50  |  Presenter: Gillianne Geet Yi Lai

      • Abstract

      Loading...

  • +

    OA05 - Value and Quality in Lung Cancer

    • 15:30 - 16:30
    • 1/29/2021
    • Location: Scientific Program Auditorium
    • IASLC CME Accredited
    • Type: Oral
    • Track: Health Services Research/Health Economics
    • +

      OA05.03 - Real-World Global Data on Targeting Epidermal Growth Factor Receptor in Stage III Non-Small Cell Lung Cancer: The Results of the KINDLE Study

      15:30 - 15:40  |  Presenter: Abdul Rahman Jazieh

      • Abstract

      Loading...

  • +

    MA04 - Health Policy and the Real World

    • 16:45 - 17:45
    • 1/29/2021
    • Location: Scientific Program Auditorium
    • IASLC CME Accredited
    • Type: Mini Oral
    • Track: Health Services Research/Health Economics
    • +

      MA04.06 - Clinical Characteristics and Outcomes in Advanced KRAS Mutant NSCLC – A Multi-Centre Collaboration in Asia (ATORG-005)

      17:15 - 17:20  |  Presenter: Jiyun Lee

      • Abstract

      Loading...